Ascorbic Acid

erythropoietin ; Homo sapiens







32 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34376935 Role of Intravenous Ascorbic Acid in the Management of Anemia in Hemodialysis Patients. 2021 May-Jun 1
2 28792166 Evaluation of Effect of Ascorbic Acid on Ferritin and Erythropoietin Resistance in Patients of Chronic Kidney Disease. 2017 Jul 3
3 27170339 Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency. 2016 Sep 4
4 26258821 Antioxidants may Attenuate Plasma Erythropoietin Decline after Hyperbaric Oxygen Diving. 2015 Nov 2
5 22227182 Vitamin C affects the expression of hepcidin and erythropoietin receptor in HepG2 cells. 2012 May 4
6 22690447 Is intravenous ascorbic acid an effective and safe option for increasing hemoglobin levels in patients with a hyporesponse to epoetin alfa? 2012 Mar-Apr 2
7 21721439 The efficacy of ascorbic acid in suboptimal responsive anemic hemodialysis patients receiving erythropoietin: a meta-analysis. 2011 Feb 3
8 18827578 Parenteral ascorbic acid in haemodialysis patients. 2008 Nov 1
9 18925528 Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study. 2008 1
10 18974579 Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia. 2008 Nov 2
11 17908648 Novel aspects of vitamin C in epoetin response. 2007 Sep 3
12 18067104 Newer strategies for anemia prevention in hemodialysis. 2007 Nov 2
13 16564942 Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. 2006 Apr 2
14 17003830 Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients. 2006 Oct 1
15 15698458 Intravenous iron preparations and ascorbic acid: effects on chelatable and bioavailable iron. 2005 Mar 1
16 16109077 Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients. 2005 Aug 1
17 15299098 Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. 2004 Sep 1
18 15339999 Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients. 2004 Sep 1
19 15645737 [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients]. 2004 1
20 12776276 Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. 2003 Jun 3
21 12803508 Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. 2003 May 2
22 12830468 Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels. 2003 Jul 1
23 11952508 Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. 2002 Apr 2
24 11509682 Erythropoietin and iron: the role of ascorbic acid. 2001 1
25 11590253 Hyporesponsiveness to recombinant human erythropoietin. 2001 1
26 10809415 Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt/V and patient weight. 2000 Apr 1
27 11014698 Intravenous vitamin C for erythropoietin resistance. 2000 Sep-Oct 1
28 11276634 Ascorbic acid use in hyporesponders to Epoetin alfa. 2000 Aug 5
29 10354297 Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. 1999 Jun 1
30 9829492 A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload. 1998 Nov 3
31 8524494 Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. 1995 3
32 1336813 Effect of Cu(2+)-ascorbic acid on lipid peroxidation, Mg(2+)-ATPase activity and spectrin of RBC membrane and reversal by erythropoietin. 1992 Dec 2 1